Zoetis | ZTS - Operating Profit


Zoetis reported $865M in Operating Profit for its fiscal quarter ending in March of 2026.





Operating Profit Change Date
AbbVie USD 4.73B 1.08B Mar/2026
Align Technology USD 178.05M 46.66M Mar/2026
Bayer EUR 3.53B 2.42B Mar/2026
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Charles River Laboratories USD 119.9M 44.08M Mar/2026
Coherus Biosciences USD -39.08M 3.65M Dec/2025
Dentsply International USD 32M 506M Mar/2026
Eli Lilly USD 9.78B 792M Mar/2026
Henry Schein USD 182M 4M Mar/2026
Idexx Laboratories USD 362.59M 46.98M Mar/2026
Illumina USD 239M 17M Mar/2026
IQVIA Holdings USD 565M 2.11B Mar/2026
J&J USD 7.48B 860M Jun/2026
Laboratory Of America USD 410.1M 28.1M Mar/2026
Merck USD -1.88B 8.12B Mar/2026
Neogen USD -3.3M 2.08M Dec/2025
Pacira USD 4.62M 1.43M Mar/2026
Perrigo USD 33.6M 50.8M Mar/2026
Pfizer USD 4.99B 340M Mar/2026
Phibro Animal Health USD 54.99M 2.36M Dec/2025
Quest Diagnostics USD 399M 13M Mar/2026
Sanofi EUR 1.94B 239M Mar/2026
Sanofi EUR 2.27B 771M Mar/2026
Zoetis USD 865M 30M Mar/2026